OLMAOlema Pharmaceuticals, Inc.

Healthcare
$7.81-25% 1Y

The financials

Olema Pharmaceuticals, Inc. by the numbers

The next results filing is expected around Nov 9, 2026, the same week as a year ago.

Olema Pharmaceuticals, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$67M−$48Mn/a
Net income−$63M−$44Mn/a
Diluted EPS−$0.61−$0.51n/a

Biotechnology

Ranks #187 of 196 by RyuScore

Compare peers
PHAR-2.6%
Pharming Group N.V.
MDXG+0.22%
MIMEDX GROUP, INC.
OABI+1.9%
OmniAb, Inc.
AURA+0.62%
Aura Biosciences, Inc.
SLDB-0.51%
Solid Biosciences Inc.
GUTS-7.4%
FRACTYL HEALTH, INC.